title: Are Th17 cells an appropriate new target in the treatment of rheumatoid arthritis?
abstract: Th17 cells play crucial roles not only in host defense but also in many human autoimmune diseases and corresponding animal models. Although many of the fundamental principles regarding Th17 biology have been rapidly elucidated in mice, there remain numerous controversies regarding the differentiation, plasticity, and pathogenicity of human Th17 cells. In this review, we consider these open questions in comparison to what has already been clarified in mice, and discuss the potential impact of discoveries related to the Th17 pathway on the development of new therapeutic strategies in Th17 driven autoimmune diseases, specifically rheumatoid arthritis.
authors.affiliation: University of Michigan Health System, Department of Internal Medicine, Division of Rheumatology, Ann Arbor, Michigan, USA.
authors.forename: Hiroshi
authors.initials: H
authors.lastname: Kato
authors.forename: David A
authors.initials: DA
authors.lastname: Fox
mesh_terms: D000818:Animals; D001172:Arthritis, Rheumatoid / Q000276:immunology* / Q000628:therapy*; D002454:Cell Differentiation / Q000276:immunology; D019070:Cell Lineage; D006801:Humans; D010641:Phenotype; D058504:Th17 Cells / Q000166:cytology / Q000276:immunology*